Filter posts

Rx Response Changes Name to Healthcare Ready

Yesterday, Rx Response announced that its name will be changing to Healthcare Ready. For nearly nine …

Riding the Bull Market: What’s in Store for Biotech Dealmakers in 2015?

In many ways, 2014 was a record year for biopharma dealmaking, with $355 billion in …

The Next Step: How Companies Build Successful Therapeutic Franchises from the Ground Up

Building a new franchise in a therapeutic from scratch poses a host of challenges, from …

Wednesday Recap of BIO 2015: What the Official Bloggers Have to Say

Everyday our BIO Official Bloggers, writers who are on top of the biotechnology beat, release …

Dr. Eric Topol's Insights on Wearables, Smart Phones, Digital Medicine Revolution

Dr. Eric Topol, director of the Scripps Translational Science Institute, is widely recognized for many …

The Future of Health and Medicine in the Digital Era

Dr. Daniel Kraft is a well-known Stanford and Harvard trained physician-scientist and innovator with over …

Complexities of Rare Diseases Take the Spotlight at BIO

Global Genes Founder & CEO Nicole Boice opened the BIO 2015 Orphan & Rare Disease …

Outdated Payments Systems Aren’t Keeping Pace With Medical Innovation

We are experiencing an era of rapid medical progress thanks to the accelerated pace at …

Expanding the Role of Patients in Drug Development

Working alongside scientists, universities, and biotech companies, patients and patient organizations have the ability to …

BIO 2015 Kicks Off: Patient-Focused Drug Development Key Theme of Day One

The BIO International Convention kicked off in Philadelphia today with a strong emphasis on patient-focused drug …